CorrespondenceUse of personal information in medical research in Japan
References (4)
The courses of the passenger and amendments of the Personal Information Protection Law
Act on the Protection of Personal Information
There are more references available in the full text version of this article.
Cited by (3)
Online molecular image repository and analysis system: A multicenter collaborative open-source infrastructure for molecular imaging research and application
2018, Computers in Biology and MedicineCitation Excerpt :In this manner, a standard practice guideline for quality control of MI could be established ensuring quality service as well as quality research. MI involves human subjects at various stages of research and clinical application; therefore, the proper management or abstraction of personal information is a critical issue [30–32]. Therefore, anonymization is essential in the cases where personal information is associated with a dataset; however, it is considerably difficult to build a unique or generic anonymization tool because regulations regarding privacy or protection of personal information vary depending on the nation [31].
Evaluation of privacy risks of patients' data in China: Case study
2020, JMIR Medical InformaticsPublic Attitudes Toward the Secondary Uses of Patient Records for Pharmaceutical Companies’ Activities in Japan
2019, Therapeutic Innovation and Regulatory Science
© 2016 Elsevier Ltd. All rights reserved.